Cargando…

Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years

We report here a patient with extremely indolent mantle cell lymphoma (MCL) who had progressed and required immunochemotherapy 20 years after diagnostic splenectomy. Non‐nodal, indolent MCL patients may progress after such an extraordinary long indolent phase, and we recommend lifelong follow up for...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsuka, Yasuyuki, Nishikori, Momoko, Kitano, Toshiyuki, Oka, Tomomi, Ishikawa, Takayuki, Haga, Hironori, Takaori‐Kondo, Akifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378856/
https://www.ncbi.nlm.nih.gov/pubmed/28396772
http://dx.doi.org/10.1002/ccr3.872
_version_ 1782519493887524864
author Otsuka, Yasuyuki
Nishikori, Momoko
Kitano, Toshiyuki
Oka, Tomomi
Ishikawa, Takayuki
Haga, Hironori
Takaori‐Kondo, Akifumi
author_facet Otsuka, Yasuyuki
Nishikori, Momoko
Kitano, Toshiyuki
Oka, Tomomi
Ishikawa, Takayuki
Haga, Hironori
Takaori‐Kondo, Akifumi
author_sort Otsuka, Yasuyuki
collection PubMed
description We report here a patient with extremely indolent mantle cell lymphoma (MCL) who had progressed and required immunochemotherapy 20 years after diagnostic splenectomy. Non‐nodal, indolent MCL patients may progress after such an extraordinary long indolent phase, and we recommend lifelong follow up for such cases.
format Online
Article
Text
id pubmed-5378856
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-53788562017-04-10 Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years Otsuka, Yasuyuki Nishikori, Momoko Kitano, Toshiyuki Oka, Tomomi Ishikawa, Takayuki Haga, Hironori Takaori‐Kondo, Akifumi Clin Case Rep Case Reports We report here a patient with extremely indolent mantle cell lymphoma (MCL) who had progressed and required immunochemotherapy 20 years after diagnostic splenectomy. Non‐nodal, indolent MCL patients may progress after such an extraordinary long indolent phase, and we recommend lifelong follow up for such cases. John Wiley and Sons Inc. 2017-03-02 /pmc/articles/PMC5378856/ /pubmed/28396772 http://dx.doi.org/10.1002/ccr3.872 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Otsuka, Yasuyuki
Nishikori, Momoko
Kitano, Toshiyuki
Oka, Tomomi
Ishikawa, Takayuki
Haga, Hironori
Takaori‐Kondo, Akifumi
Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years
title Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years
title_full Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years
title_fullStr Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years
title_full_unstemmed Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years
title_short Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years
title_sort persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378856/
https://www.ncbi.nlm.nih.gov/pubmed/28396772
http://dx.doi.org/10.1002/ccr3.872
work_keys_str_mv AT otsukayasuyuki persistenceofat1114positivecloneinapatientwithmantlecelllymphomafor20years
AT nishikorimomoko persistenceofat1114positivecloneinapatientwithmantlecelllymphomafor20years
AT kitanotoshiyuki persistenceofat1114positivecloneinapatientwithmantlecelllymphomafor20years
AT okatomomi persistenceofat1114positivecloneinapatientwithmantlecelllymphomafor20years
AT ishikawatakayuki persistenceofat1114positivecloneinapatientwithmantlecelllymphomafor20years
AT hagahironori persistenceofat1114positivecloneinapatientwithmantlecelllymphomafor20years
AT takaorikondoakifumi persistenceofat1114positivecloneinapatientwithmantlecelllymphomafor20years